Jonathan H. Kaufman - 13 Mar 2024 Form 4 Insider Report for LIPELLA PHARMACEUTICALS INC. (LIPO)

Role: President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors, Director, 10%+ Owner
Signature: /s/ Jonathan H. Kaufman
Issuer symbol: LIPO
Transactions as of: 13 Mar 2024
Transactions value $: $100,000
Form type: 4
Filing time: 15 Mar 2024, 12:20:56 UTC
Previous filing: 21 Jun 2023
Next filing: 19 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LIPO	Common Stock	Award	$100,000	+144,906	+21%	$0.6901	833,849	13 Mar 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of shares of Common Stock has been increased by two from the number of shares reported as directly owned in the Form 4 filed by the reporting person on June 21, 2023 in order to correct an inadvertent administrative error in such prior Form 4.

Remarks:

President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors